Investigation of Drug for Pulmonary Administration-Model Pulmonary Surfactant Monolayer Interactions Using Langmuir-Blodgett Monolayer and Molecular Dynamics Simulation : A Case Study of Ketoprofen

Pulmonary administration is widely used for the treatment of lung diseases. The interaction between drug molecules and pulmonary surfactants affects the efficacy of the drug directly. The location and distribution of drug molecules in a model pulmonary surfactant monolayer under different surface pr...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Langmuir : the ACS journal of surfaces and colloids. - 1992. - 35(2019), 41 vom: 15. Okt., Seite 13452-13460
1. Verfasser: Hu, Jiajie (VerfasserIn)
Weitere Verfasser: Liu, Hengjiang, Xu, Pu, Shang, Yazhuo, Liu, Honglai
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2019
Zugriff auf das übergeordnete Werk:Langmuir : the ACS journal of surfaces and colloids
Schlagworte:Journal Article Research Support, Non-U.S. Gov't Phosphatidylglycerols Pulmonary Surfactants 1,2-Dipalmitoylphosphatidylcholine 2644-64-6 Ketoprofen 90Y4QC304K
LEADER 01000naa a22002652 4500
001 NLM301328471
003 DE-627
005 20231225104410.0
007 cr uuu---uuuuu
008 231225s2019 xx |||||o 00| ||eng c
024 7 |a 10.1021/acs.langmuir.9b02412  |2 doi 
028 5 2 |a pubmed24n1004.xml 
035 |a (DE-627)NLM301328471 
035 |a (NLM)31524404 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Hu, Jiajie  |e verfasserin  |4 aut 
245 1 0 |a Investigation of Drug for Pulmonary Administration-Model Pulmonary Surfactant Monolayer Interactions Using Langmuir-Blodgett Monolayer and Molecular Dynamics Simulation  |b A Case Study of Ketoprofen 
264 1 |c 2019 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Completed 03.09.2020 
500 |a Date Revised 03.09.2020 
500 |a published: Print-Electronic 
500 |a Citation Status MEDLINE 
520 |a Pulmonary administration is widely used for the treatment of lung diseases. The interaction between drug molecules and pulmonary surfactants affects the efficacy of the drug directly. The location and distribution of drug molecules in a model pulmonary surfactant monolayer under different surface pressures can provide vivid information on the interaction between drug molecules and pulmonary surfactants during the pulmonary administration. Ketoprofen is a nonsteroidal anti-inflammatory drug for pulmonary administration. The effect of ketoprofen molecules on the lipid monolayer containing 1,2-dipalmitoyl-sn-glycero-3-phosphatidylcholine (DPPC) and 1,2-dipalmitoyl-sn-glycero-3-phospho-rac-glycerol (DPPG) is studied by surface pressure (π)-area (A) isotherms and compressibility modulus (Cs-1)-surface pressure (π) isotherms. The location and distribution of ketoprofen molecules in a lipid monolayer under different surface pressures are explored by surface tension, density profile, radial distribution function (RDF), and the potential of mean force (PMF) simulated by molecular dynamics (MD) simulation. The introduction of ketoprofen molecules affects the properties of DPPC/DPPG monolayers and the location and distribution of ketoprofen molecules in monolayers with various surface pressures. The existence of ketoprofen molecules hinders the formation of liquid-condensed (LC) films and decreases the compressibility of DPPC/DPPG monolayers. The location and distribution of ketoprofen molecules in the lipid monolayer are affected by cation-π interaction between the choline group of lipids and the benzene ring of ketoprofen, the steric hindrance of the lipid head groups, and the hydrophobicity of ketoprofen molecule itself, comprehensively. The contact state of lipid head group with water is determined by surface pressure, which affects the interaction between drug molecules and lipids and further dominates the location and distribution of ketoprofen in the lipid monolayer. This work confirms that ketoprofen molecules can affect the property and the inner structure of DPPC/DPPG monolayers during breathing. Furthermore, the results obtained using a mixed monolayer containing two major pulmonary surfactants DPPC/DPPG and ketoprofen molecules will be helpful for the in-depth understanding of the mechanism of inhaled administration therapy 
650 4 |a Journal Article 
650 4 |a Research Support, Non-U.S. Gov't 
650 7 |a Phosphatidylglycerols  |2 NLM 
650 7 |a Pulmonary Surfactants  |2 NLM 
650 7 |a 1,2-Dipalmitoylphosphatidylcholine  |2 NLM 
650 7 |a 2644-64-6  |2 NLM 
650 7 |a Ketoprofen  |2 NLM 
650 7 |a 90Y4QC304K  |2 NLM 
700 1 |a Liu, Hengjiang  |e verfasserin  |4 aut 
700 1 |a Xu, Pu  |e verfasserin  |4 aut 
700 1 |a Shang, Yazhuo  |e verfasserin  |4 aut 
700 1 |a Liu, Honglai  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Langmuir : the ACS journal of surfaces and colloids  |d 1992  |g 35(2019), 41 vom: 15. Okt., Seite 13452-13460  |w (DE-627)NLM098181009  |x 1520-5827  |7 nnns 
773 1 8 |g volume:35  |g year:2019  |g number:41  |g day:15  |g month:10  |g pages:13452-13460 
856 4 0 |u http://dx.doi.org/10.1021/acs.langmuir.9b02412  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_22 
912 |a GBV_ILN_350 
912 |a GBV_ILN_721 
951 |a AR 
952 |d 35  |j 2019  |e 41  |b 15  |c 10  |h 13452-13460